產品搜尋
新聞
The Nitto website is currently under system maintenance.
Please try again later.
Please try again later.
- 2019/Apr/26
- Announcement of Financial Results of FY2018
- 2019/Apr/26
- Notice Regarding Change in Appointment of Representative Director
- 2019/Mar/22
- 2019/Apr/26 Announcement of Financial Results for Fiscal 2018
- 2019/Feb/28
- Notice Concerning Basic Policy on the Holding and Cancellation of Treasury Shares
- 2019/Feb/27
- 援助聯合國兒童基金會所舉辦之 Nitto ATP Finals 慈善活動
The Nitto website is currently under system maintenance.
Please try again later.
Please try again later.
- 2019/Feb/27
- 援助聯合國兒童基金會所舉辦之 Nitto ATP Finals 慈善活動
- 2019/Jan/23
- Nitto 被評選為 2018 至 2019 年度德溫特全球百大創新機構，此為連續第八年獲此殊榮
- 2019/Jan/08
- Bisono®貼布於日本獲得 2 毫克強度以及 4 毫克、8 毫克強度改良配方之額外核准。此經皮貼布含 β１ 受體阻滯劑，作為心房顫動之治療用途
- 2018/Dec/21
- Nitto ATP Finals 慈善計劃的相關報導
- 2018/Nov/29
- Nitto 宣布用於治療在癌症末期病患身上 KRAS 驅動腫瘤的 NBF-006 獲得 FDA 核准進行第一期臨床試驗
